Current NDC auxiliary source row compounder:1921

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 69374-919
Product Ndc: 69374-919
Product Ndc Digits: 69374919
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Succinylcholine Chloride 20mg/mL
Proprietary Name Suffix: [empty]
Nonproprietary Name: Succinylcholine Chloride 20mg/mL
Dosage Form Name: INJECTION, SOLUTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Nephron Sterile Compounding Center, LLC
Establishment Name: Nephron Sterile Compounding Center, LLC
Establishment Fei: [empty]
Substance Name: SUCCINYLCHOLINE CHLORIDE
Active Ingredients Info: 20 mg/1 mL
History Active Ingredients Raw: SUCCINYLCHOLINE CHLORIDE
History Active Ingredients Info Raw: 20 mg/1 mL
History Dosage Raw: INJECTION, SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 69374-919-10
Package Ndc: 69374-919-10
Package Ndc Digits: 6937491910
Package Ndc11: 69374091910
Package Description: 5 SYRINGE, PLASTIC in 1 CARTON (69374-919-10) > 10 mL in 1 SYRINGE, PLASTIC
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:1921
Source Row Number: 1921
Source Row Hash: 12596adf245904a406253d7cdfd049b14836d18fe34d8d94ddfe7515dce2b986
Import Run Id: 20261024T113518Z
Loaded At: 2026-10-24 11:40:19

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "69374-919",
    "DEASCHEDULE": "",
    "LABELERNAME": "Nephron Sterile Compounding Center, LLC",
    "SUBSTANCENAME": "SUCCINYLCHOLINE CHLORIDE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "69374-919-10",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Succinylcholine Chloride 20mg/mL",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Succinylcholine Chloride 20mg/mL",
    "PACKAGEDESCRIPTION": "5 SYRINGE, PLASTIC in 1 CARTON (69374-919-10)  > 10 mL in 1 SYRINGE, PLASTIC",
    "ACTIVEINGREDIENTSINFO": "20 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:1921
Source Row Number: 1921
Status Scope: package
Lookup Ndc: 69374-919-10
Lookup Ndc Digits: 6937491910
Product Ndc: 69374-919
Product Ndc Digits: 69374919
Package Ndc: 69374-919-10
Package Ndc Digits: 6937491910
Package Ndc11: 69374091910
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 12596adf245904a406253d7cdfd049b14836d18fe34d8d94ddfe7515dce2b986
Import Run Id: 20261024T113518Z
Loaded At: 2026-10-24 11:40:19